CHRISTINE BLOOMQUIST

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Coverage Gap Discount Cancer Care Payment Reform Act (S 463, H 1834) Oncology Care Model - CMS Medicaid Rebate issues

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Coverage Gap Discount Cancer Care Payment Reform Act (S 463, H 1834) Oncology Care Model - CMS

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Coverage Gap Discount Cancer Care Payment Reform Act (S 463, H 1834) Oncology Care Model - CMS

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Innovative Payments Vaccines for Children program

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Medicaid Coverage Coverage Gap Discount Cancer Care Payment Reform Act (S 463, H 1834) Oncology Care Model - CMS Medicaid Rebate issues

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Innovative Payments Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Vaccines for Children program

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint Drug pricing

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic prior authorization (ePA) bill (HR 4841)/ H.R. 5773, the Preventing Addiction Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program Presidents Drug Pricing Blueprint

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Innovative Payments Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Vaccines for Children program

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) STRIKE Act - Senate Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 3211)

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2128, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

H.R. 2128, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

H.R. 2128, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2190, S.1206 and related legislation proposals regarding changes/scope of Medicare Part D Rebates H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011

HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2190, S.1206 and related legislation proposals regarding changes/scope of Medicare Part D Rebates H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2190, S.1206 and related legislation proposals regarding changes/scope of Medicare Part D Rebates H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

H.R. 2245, S. 296, H.R. 3839 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements H.R. 2245, S. 296, H.R. 3839(Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics H.R. 452 IPAB (Independent Payment Advisory Board) Medicare Decisions Accountability Act of 2011 S.1882, H.R. 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer; HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 3468 - issues related to increased penalties for counterfeiting drugs Discussions regarding use of psychotropic drugs by children in foster care HR 1254 (Synthetic Drug Control Act) - issues related to propsed controlled substance amendments S 2113 (Transforming Regulatory Environment to Accelerate Access to Treatments Act) - issues related to acceleration of innovation and approvals of medical treatments